Global Theranostics Market Size by Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological, Immunological Disorders), by Technology (PCR, IHC, ISH, Sequencing) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1261437
  • |
  • Publishe Date : September 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

Theranostics is referred to as the combination of therapeutics, nanoscience, and diagnostics that provides a transition from conventional medicine to a contemporary personalized and precision medicine approach. It is a new field of medicine which combines specific targeted therapy based on specific targeted diagnostic tests.

The global theranostics market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. The development of novel companion diagnostic tests, mounting adoption of companion diagnostic tests by end users, increasing collaborations and partnerships by prominent market participants to develop innovative companion diagnostics, and rising burden of chronic diseases are the factors fueling the market growth globally. However, the lack of properly defined regulations for theranostics tests and inadequate reimbursement facilities in most of the economies are the major factors expected to hamper the growth of the global market.

The global theranostics market is primarily segmented based on different therapeutic area, technology, and regions. On the basis of therapeutic area, the market is divided into oncology, cardiovascular diseases, neurological disorders, immunological disorders, and others. Depending on technology, it is categorized into polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH), sequencing, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, South America, and MEA.

On the basis of therapeutic area, the market is split into:
* Oncology
* Cardiovascular Diseases
* Neurological Disorders
* Immunological Disorders
* Other Therapeutic Areas

On the basis of technology, the market is split into:
* Polymerase Chain Reaction (PCR)
* Immunohistochemistry (IHC)
* In Situ Hybridization (ISH)
* Sequencing
* Other Technologies

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Luminex Corporation
* Thermo Fisher Scientific Inc.
* Illumina Inc.
* Bio-Rad Laboratories Inc.
* QIAGEN N.V.
* Beckman Coulter, Inc.
* Abbott Laboratories
* Agilent Technologies, Inc.
* Meso Scale Diagnostics LLC
* Randox Laboratories Ltd.

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, therapeutic area, and technology market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions, therapeutic area, and technology with qualitative and quantitative information and facts

Target Audience:
* Theranostics Equipment Manufacturers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Theranostics Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Theranostics Market - Porter\'s Five Forces Analysis
4.4. Global Theranostics Market - PESTEL Analysis

5. Global Theranostics Market, by Therapeutic Area
5.1. Global Theranostics Market, Size and Forecast, 2015-2026
5.2. Global Theranostics Market, by Oncology, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Theranostics Market, by Cardiovascular Diseases, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Theranostics Market, by Neurological Disorders, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026
5.5. Global Theranostics Market, by Immunological Disorders, 2015-2026
5.5.1. Key driving factors, trends and opportunities
5.5.2. Market size and forecast, 2015-2026
5.6. Global Theranostics Market, by Other Therapeutic Areas, 2015-2026
5.6.1. Key driving factors, trends and opportunities
5.6.2. Market size and forecast, 2015-2026

6. Global Theranostics Market, by Technology
6.1. Global Theranostics Market, Size and Forecast, 2015-2026
6.2. Global Theranostics Market, by Polymerase Chain Reaction, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Theranostics Market, by Immunohistochemistry, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Theranostics Market, by In Situ Hybridization, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026
6.5. Global Theranostics Market, by Sequencing, 2015-2026
6.5.1. Key driving factors, trends and opportunities
6.5.2. Market size and forecast, 2015-2026
6.6. Global Theranostics Market, by Other Technologies, 2015-2026
6.6.1. Key driving factors, trends and opportunities
6.6.2. Market size and forecast, 2015-2026

7. Global Theranostics Market, by Region
7.1. Theranostics Market Regional Analysis, 2015-2026
7.2. Global Theranostics Market Revenue (USD Million) by Region, 2015-2026
7.3. North America Theranostics Market, 2015-2026
7.3.1. North America Theranostics Market Size and Forecast, 2015-2026
7.3.2. North America Theranostics Market by Country, 2015-2026
7.3.2.1. U.S. Theranostics Market, 2015-2026
7.3.2.2. Canada Theranostics Market, 2015-2026
7.4. Europe Theranostics Market, 2015-2026
7.4.1. Europe Theranostics Market Size and Forecast, 2015-2026
7.4.2. Europe Theranostics Market by Country, 2015-2026
7.4.2.1. Germany Theranostics Market, 2015-2026
7.4.2.2. France Theranostics Market, 2015-2026
7.4.2.3. Italy Theranostics Market, 2015-2026
7.4.2.4. UK Theranostics Market, 2015-2026
7.4.2.5. Spain Theranostics Market, 2015-2026
7.4.2.6. Rest of Europe Theranostics Market, 2015-2026
7.5. Asia Pacific Theranostics Market, 2015-2026
7.5.1. Asia Pacific Theranostics Market Size and Forecast, 2015-2026
7.5.2. Asia Pacific Theranostics Market by Country, 2015-2026
7.5.2.1. Japan Theranostics Market, 2015-2026
7.5.2.2. China Theranostics Market, 2015-2026
7.5.2.3. India Theranostics Market, 2015-2026
7.5.2.4. Rest of Asia Pacific Theranostics Market, 2015-2026
7.6. South America Theranostics Market, 2015-2026
7.6.1. South America Theranostics Market Size and Forecast, 2015-2026
7.6.2. South America Theranostics Market by Country, 2015-2026
7.6.2.1. Mexico Theranostics Market, 2015-2026
7.6.2.2. Brazil Theranostics Market, 2015-2026
7.6.2.3. Rest of South America Theranostics Market, 2015-2026
7.7. Middle East & Africa Theranostics Market, 2015-2026
7.7.1. Middle East & Africa Theranostics Market Size and Forecast, 2015-2026
7.7.2. Middle East & Africa Theranostics Market by Country, 2015-2026
7.7.2.1. Saudi Arabia Theranostics Market, 2015-2026
7.7.2.2. South Africa Theranostics Market, 2015-2026
7.7.2.3. Rest of Middle East & Africa Theranostics Market, 2015-2026

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis/Top Player Positioning, 2018

9. Company Profiles
9.1. Luminex Corporation
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Product Benchmarking
9.1.4. Key Developments
9.2. Thermo Fisher Scientific Inc.
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Product Benchmarking
9.2.4. Key Developments
9.3. Illumina Inc.
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Product Benchmarking
9.3.4. Key Developments
9.4. Bio-Rad Laboratories Inc.
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Product Benchmarking
9.4.4. Key Developments
9.5. QIAGEN N.V.
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Product Benchmarking
9.5.4. Key Developments
9.6. Beckman Coulter, Inc.
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Product Benchmarking
9.6.4. Key Developments
9.7. Abbott Laboratories
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Product Benchmarking
9.7.4. Key Developments
9.8. Agilent Technologies, Inc.
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Product Benchmarking
9.8.4. Key Developments
9.9. Meso Scale Diagnostics LLC
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Product Benchmarking
9.9.4. Key Developments
9.10. Randox Laboratories Ltd.
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Product Benchmarking
9.10.4. Key Developments

10. Key Insights

Content are not available

Choose License Type